Summary
McKesson Corporation reported strong financial results for the nine months ended December 31, 2015, with revenues increasing by 8% to $144.2 billion and net income attributable to McKesson Corporation growing by 36% to $1.83 billion. This growth was driven by robust performance in its Distribution Solutions segment, particularly in North America, which saw an 12% increase in revenue. The company also demonstrated improved profitability, with income from continuing operations before income taxes rising 27% year-over-year. Operationally, McKesson managed its expenses effectively, with a decrease in operating expenses as a percentage of revenues. The company also returned capital to shareholders through dividends and share repurchases, signaling confidence in its financial stability and future prospects. While facing some international revenue headwinds due to currency fluctuations and specific market challenges, the overall financial health and operational execution remain positive, indicating a solid performance for the period.
Financial Highlights
53 data points| Revenue | $47.90B |
| Cost of Revenue | $45.03B |
| Gross Profit | $2.87B |
| Operating Expenses | $1.95B |
| Operating Income | $920.00M |
| Net Income | $634.00M |
| EPS (Basic) | $2.76 |
| EPS (Diluted) | $2.73 |
| Shares Outstanding (Basic) | 230.00M |
| Shares Outstanding (Diluted) | 232.00M |
Key Highlights
- 1Revenue increased 8% to $144.2 billion for the nine months ended December 31, 2015, driven by the Distribution Solutions segment.
- 2Net income attributable to McKesson Corporation surged by 36% to $1.83 billion for the nine-month period.
- 3Diluted Earnings Per Common Share (EPS) grew by 37% to $7.81 for the nine months, demonstrating enhanced profitability on a per-share basis.
- 4Operating income from continuing operations increased significantly, reflecting improved operational efficiency and strong demand.
- 5The company actively managed its debt, with a notable decrease in its debt-to-capital ratio to 44.8% from 50.3%.
- 6McKesson returned capital to shareholders, with dividends paid and a significant share repurchase program in place, totaling $1.6 billion authorized for repurchase at the end of the period.
- 7Acquisitions are being strategically integrated, with ongoing efforts in acquiring businesses like UDG Healthcare Plc and J Sainsbury Plc, expected to contribute to future growth.